Transthyretin (TTR) is a plasma protein in which most of the coding re
gion is constituted of three exons, each one of approximately 200 bp.
Several TTR variants have been reported in association with familial a
myloid polyneuropathy (FAP) and the characterization of the mutations
is crucial for understanding the process of amyloidogenesis. In order
to simplify mutation screening and DNA sequencing studies, a method of
exon scanning was developed employing duplex amplification of exon 2/
3 and individual amplification of exon 4 followed by single strand con
formation polymorphism analysis (SSCPs) on acrylamide gels and silver
staining. In this work, 22 different known TTR mutations were discrimi
nated and studies on 210 samples from patients with peripheral neuropa
thies detected one polymorphic mutation (TTR Ser 6), TTR Asn 90, found
previously in the normal Portuguese and German populations, and three
other mutations, one of them TTR Ala 60.